RHYTHM PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q3 2016 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Rhythm Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2016 to Q2 2024.
Rhythm Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$40.5M, a 13.1% increase year-over-year.
Rhythm Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$266M, a 47.1% decline year-over-year.
Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$184M, a 2.9% decline from 2022.
Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$179M, a 5.35% decline from 2021.
Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$170M, a 24.5% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$266M	-$40.5M	+$6.13M	+13.1%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	-$272M	-$140M	-$87.4M	-166%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	-$184M	-$41.3M	+$834K	+1.98%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-29
Q3 2023	-$185M	-$44M	-$4.69M	-11.9%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	-$181M	-$46.6M	-$1.51M	-3.34%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-06
Q1 2023	-$179M	-$52.5M	+$160K	+0.3%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	-$179M	-$42.1M	+$8.89M	+17.4%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-29
Q3 2022	-$188M	-$39.3M	+$4.97M	+11.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	-$193M	-$45.1M	-$4.66M	-11.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-01
Q1 2022	-$188M	-$52.7M	-$18.3M	-53.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-02
Q4 2021	-$170M	-$51M	-$15.9M	-45.4%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-29
Q3 2021	-$154M	-$44.2M	-$9.96M	-29%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	-$144M	-$40.4M	-$8.51M	-26.7%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-03
Q1 2021	-$136M	-$34.4M	+$902K	+2.56%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-03
Q4 2020	-$137M	-$35.1M	-$849K	-2.48%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-01
Q3 2020	-$136M	-$34.3M	+$2.82M	+7.61%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-02
Q2 2020	-$139M	-$31.9M	+$12.2M	+27.7%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-03
Q1 2020	-$151M	-$35.3M	-$4.78M	-15.7%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-03
Q4 2019	-$146M	-$34.2M	-$7.07M	-26.1%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-01
Q3 2019	-$139M	-$37.1M	-$17.9M	-92.8%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-02
Q2 2019	-$121M	-$44.1M	-$29.1M	-194%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-03
Q1 2019	-$91.9M	-$30.5M	-$13.5M	-79.5%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-04
Q4 2018	-$78.4M	-$27.2M	-$16.2M	-147%	Oct 1, 2018	Dec 31, 2018	10-K	2021-03-01
Q3 2018	-$62.2M	-$19.2M	-$11M	-132%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-01
Q2 2018	-$51.3M	-$15M	-$8.27M	-122%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-29
Q1 2018	-$43M	-$17M	-$10.6M	-166%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-03
Q4 2017	-$32.4M	-$11M			Oct 1, 2017	Dec 31, 2017	10-K	2020-03-02
Q3 2017		-$8.29M	-$1.89M	-29.4%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-09
Q2 2017		-$6.75M			Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-08
Q1 2017		-$6.39M			Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-14
Q3 2016		-$6.4M			Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.